血管的心脏神经移除:一个更新的系统审查和单臂元分析
Alexandru Ababei1,2, Cosmin Gabriel Ursu2, Mircea Ioan Alexandru Bistriceanu2
1Iliescu Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania.
Biomedicines
|July 29, 2025
概括
状膜导管切除可能会减少精选患者的血管 (VVS) 复发. 然而,目前研究中的高度异质性需要进一步的随机试验来确定有效性和安全性.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 医疗干预 医疗干预
背景情况:
- 当保守治疗失败时,血管 (VVS) 可能会使人衰弱.
- 永久心脏起器和状 (GP) 导管切除是耐火性VVS的程序替代方案.
研究的目的:
- 评估GP导管切除在患有血管综合症的患者中的疗效.
- 综合现有的关于VVS消去后复发率的证据.
主要方法:
- 在主要数据库 (PubMed,Embase,Cochrane图书馆) 进行了全面的文献搜索.
- 对37项涉及1585名参与者的研究进行了单臂比例元分析.
- 研究选择和数据提取由两个独立的审稿人进行.
主要成果:
- 在GP导管切除后,VVS的综合复发率为8.9% (95% CI,6.4-11.4%).
- 在研究中观察到显著的异质性 (I2 = 74.4%,p < 0.001).
- 灵敏度,子组和元回归分析没有确定显著的效果修饰剂或解决异质性.
结论:
- 在特定的患者群体中,GP导管切除显示出减少VVS复发的潜力.
- 目前的证据主要来自非随机研究,限制了最终的结论.
- 高异质性强调了未来需要使用标准化协议进行随机对照试验的必要性.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
78
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
78
Dysrhythmias VI: Management of Dysrhythmias
107
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
107
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
Cardiopulmonary Resuscitation III: AED Use
70
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
70
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
168
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
168


